<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35652455</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-2083</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>20</Issue><PubDate><Year>2022</Year><Month>Oct</Month><Day>10</Day></PubDate></JournalIssue><Title>Human molecular genetics</Title><ISOAbbreviation>Hum Mol Genet</ISOAbbreviation></Journal><ArticleTitle>Gene expression profiles in sporadic ALS fibroblasts define disease subtypes and the metabolic effects of the investigational drug EH301.</ArticleTitle><Pagination><StartPage>3458</StartPage><EndPage>3477</EndPage><MedlinePgn>3458-3477</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/hmg/ddac118</ELocationID><Abstract><AbstractText>Metabolic alterations shared between the nervous system and skin fibroblasts have emerged in amyotrophic lateral sclerosis (ALS). Recently, we found that a subgroup of sporadic ALS (sALS) fibroblasts (sALS1) is characterized by metabolic profiles distinct from other sALS cases (sALS2) and controls, suggesting that metabolic therapies could be effective in sALS. The metabolic modulators nicotinamide riboside and pterostilbene (EH301) are under clinical development for the treatment of ALS. Here, we studied the transcriptome and metabolome of sALS cells to understand the molecular bases of sALS metabotypes and the impact of EH301. Metabolomics and transcriptomics were investigated at baseline and after EH301 treatment. Moreover, weighted gene coexpression network analysis (WGCNA) was used to investigate the association of the metabolic and clinical features. We found that the sALS1 transcriptome is distinct from sALS2 and that EH301 modifies gene expression differently in sALS1, sALS2 and the controls. Furthermore, EH301 had strong protective effects against metabolic stress, an effect linked to the antiinflammatory and antioxidant pathways. WGCNA revealed that the ALS functional rating scale and metabotypes are associated with gene modules enriched for the cell cycle, immunity, autophagy and metabolic genes, which are modified by EH301. The meta-analysis of publicly available transcriptomic data from induced motor neurons by Answer ALS confirmed the functional associations of genes correlated with disease traits. A subset of genes differentially expressed in sALS fibroblasts was used in a machine learning model to predict disease progression. In conclusion, multiomic analyses highlighted the differential metabolic and transcriptomic profiles in patient-derived fibroblast sALS, which translate into differential responses to the investigational drug EH301.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2022. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fels</LastName><ForeName>Jasmine A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, 407 East 61st Street, New York, NY 10065, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Graduate Program, Weill Cornell Graduate School of Medical Sciences, 1300 York Ave, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casalena</LastName><ForeName>Gabriella</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, 407 East 61st Street, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konrad</LastName><ForeName>Csaba</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, 407 East 61st Street, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holmes</LastName><ForeName>Holly E</ForeName><Initials>HE</Initials><AffiliationInfo><Affiliation>Elysium Health New York, New York, NY 10013, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dellinger</LastName><ForeName>Ryan W</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Elysium Health New York, New York, NY 10013, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manfredi</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, 407 East 61st Street, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R35 NS122209</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Hum Mol Genet</MedlineTA><NlmUniqueID>9208958</NlmUniqueID><ISSNLinking>0964-6906</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000975">Antioxidants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015507">Drugs, Investigational</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C531617">Amyotrophic lateral sclerosis 1</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000975" MajorTopicYN="N">Antioxidants</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015507" MajorTopicYN="N">Drugs, Investigational</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>52</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35652455</ArticleId><ArticleId IdType="pmc">PMC9558834</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddac118</ArticleId><ArticleId IdType="pii">6597094</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Turner, M.R., Al-Chalabi, A., Chio, A., Hardiman, O., Kiernan, M.C., Rohrer, J.D., Rowe, J., Seeley, W. and Talbot, K. (2017) Genetic screening in sporadic ALS and FTD. J. Neurol. Neurosurg. Psychiatry, 88, 1042&#x2013;1044.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5740553</ArticleId><ArticleId IdType="pubmed">28642287</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan, M.C., Vucic, S., Talbot, K., McDermott, C.J., Hardiman, O., Shefner, J.M., Al-Chalabi, A., Huynh, W., Cudkowicz, M., Talman, P. &#xa0;et al. (2021) Improving clinical trial outcomes in amyotrophic lateral sclerosis. Nat. Rev. Neurol., 17, 104&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7747476</ArticleId><ArticleId IdType="pubmed">33340024</ArticleId></ArticleIdList></Reference><Reference><Citation>Huisman, M.H., Seelen, M., van &#xa0;Doormaal, P.T., de &#xa0;Jong, S.W., de &#xa0;Vries, J.H., van der &#xa0;Kooi, A.J., de &#xa0;Visser, M., Schelhaas, H.J., van den &#xa0;Berg, L.H. and Veldink, J.H. (2015) Effect of presymptomatic body mass index and consumption of fat and alcohol on amyotrophic lateral sclerosis. JAMA Neurol, 72, 1155&#x2013;1162.</Citation><ArticleIdList><ArticleId IdType="pubmed">26280944</ArticleId></ArticleIdList></Reference><Reference><Citation>Cistaro, A., Valentini, M.C., Chio, A., Nobili, F., Calvo, A., Moglia, C., Montuschi, A., Morbelli, S., Salmaso, D., Fania, P. &#xa0;et al. (2012) Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset. Eur. J. Nucl. Med. Mol. Imaging, 39, 251&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pubmed">22089661</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyn, F.J., Ioannides, Z.A., van &#xa0;Eijk, R.P.A., Heggie, S., Thorpe, K.A., Ceslis, A., Heshmat, S., Henders, A.K., Wray, N.R., van den &#xa0;Berg, L.H. &#xa0;et al. (2018) Hypermetabolism in ALS is associated with greater functional decline and shorter survival. J. Neurol. Neurosurg. Psychiatry, 89, 1016&#x2013;1023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6166607</ArticleId><ArticleId IdType="pubmed">29706605</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirk, K., Gennings, C., Hupf, J.C., Tadesse, S., D'Aurelio, M., Kawamata, H., Valsecchi, F., Mitsumoto, H., Groups, A.P.C.S. and Manfredi, G. (2014) Bioenergetic markers in skin fibroblasts of sporadic amyotrophic lateral sclerosis and progressive lateral sclerosis patients. Ann. Neurol., 76, 620&#x2013;624.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4192005</ArticleId><ArticleId IdType="pubmed">25090982</ArticleId></ArticleIdList></Reference><Reference><Citation>Konrad, C., Kawamata, H., Bredvik, K.G., Arreguin, A.J., Cajamarca, S.A., Hupf, J.C., Ravits, J.M., Miller, T.M., Maragakis, N.J., Hales, C.M. &#xa0;et al. (2017) Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients. Mol. Neurodegener., 12, 76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5655870</ArticleId><ArticleId IdType="pubmed">29065921</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, Q., Konrad, C., Sandhu, D., Roychoudhury, D., Schwartz, B.I., Cheng, R.R., Bredvik, K., Kawamata, H., Calder, E.L., Studer, L. &#xa0;et al. (2020) Accelerated transsulfuration metabolically defines a discrete subclass of amyotrophic lateral sclerosis patients. Neurobiol. Dis., 144, 105025.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491150</ArticleId><ArticleId IdType="pubmed">32745521</ArticleId></ArticleIdList></Reference><Reference><Citation>Belenky, P., Bogan, K.L. and Brenner, C. (2007) NAD+ metabolism in health and disease. Trends Biochem. Sci., 32, 12&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">17161604</ArticleId></ArticleIdList></Reference><Reference><Citation>Massudi, H., Grant, R., Braidy, N., Guest, J., Farnsworth, B. and Guillemin, G.J. (2012) Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLoS One, 7, e42357.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3407129</ArticleId><ArticleId IdType="pubmed">22848760</ArticleId></ArticleIdList></Reference><Reference><Citation>Harlan, B.A., Killoy, K.M., Pehar, M., Liu, L., Auwerx, J. and Vargas, M.R. (2020) Evaluation of the NAD(+) biosynthetic pathway in ALS patients and effect of modulating NAD(+) levels in hSOD1-linked ALS mouse models. Exp. Neurol., 327, 113219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7089832</ArticleId><ArticleId IdType="pubmed">32014438</ArticleId></ArticleIdList></Reference><Reference><Citation>Harlan, B.A., Pehar, M., Sharma, D.R., Beeson, G., Beeson, C.C. and Vargas, M.R. (2016) Enhancing NAD+ salvage pathway reverts the toxicity of primary astrocytes expressing amyotrophic lateral sclerosis-linked mutant superoxide dismutase 1 (SOD1). J. Biol. Chem., 291, 10836&#x2013;10846.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4865928</ArticleId><ArticleId IdType="pubmed">27002158</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger, R.W., Santos, S.R., Morris, M., Evans, M., Alminana, D., Guarente, L. and Marcotulli, E. (2017) Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD(+) levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study. NPJ Aging Mech. Dis., 3, 17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5701244</ArticleId><ArticleId IdType="pubmed">29184669</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, Y.R., Li, S. and Lin, C.C. (2018) Effect of resveratrol and pterostilbene on aging and longevity. Biofactors, 44, 69&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">29210129</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, P. and Sang, S. (2018) Metabolism and pharmacokinetics of resveratrol and pterostilbene. Biofactors, 44, 16&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">29315886</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez-Zorita, S., Milton-Laskibar, I., Aguirre, L., Fernandez-Quintela, A., Xiao, J. and Portillo, M.P. (2021) Effects of pterostilbene on diabetes, liver steatosis and serum lipids. Curr. Med. Chem., 28, 238&#x2013;252.</Citation><ArticleIdList><ArticleId IdType="pubmed">31663469</ArticleId></ArticleIdList></Reference><Reference><Citation>Freyssin, A., Page, G., Fauconneau, B. and Rioux Bilan, A. (2020) Natural stilbenes effects in animal models of Alzheimer's disease. Neural Regen. Res., 15, 843&#x2013;849.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6990773</ArticleId><ArticleId IdType="pubmed">31719245</ArticleId></ArticleIdList></Reference><Reference><Citation>Obrador, E., Salvador, R., Marchio, P., Lopez-Blanch, R., Jihad-Jebbar, A., Rivera, P., Valles, S.L., Banacloche, S., Alcacer, J., Colomer, N. &#xa0;et al. (2020) Nicotinamide riboside and pterostilbene cooperatively delay motor neuron failure in ALS SOD1(G93A) mice. Mol. Neurobiol., 58, 1345&#x2013;1371.</Citation><ArticleIdList><ArticleId IdType="pubmed">33174130</ArticleId></ArticleIdList></Reference><Reference><Citation>de la &#xa0;Rubia, J.E., Drehmer, E., Platero, J.L., Benlloch, M., Caplliure-Llopis, J., Villaron-Casales, C., de &#xa0;Bernardo, N., AlarcOn, J., Fuente, C., Carrera, S. &#xa0;et al. (2019) Efficacy and tolerability of EH301 for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled human pilot study. Amyotroph Lateral Scler. Frontotemporal Degener., 20, 115&#x2013;122.</Citation><ArticleIdList><ArticleId IdType="pubmed">30668199</ArticleId></ArticleIdList></Reference><Reference><Citation>
NO-ALS . https://clinicaltrials.gov/ct2/show/NCT04562831?term=eh301&amp;cond=ALS&amp;draw=2&amp;rank=2.</Citation></Reference><Reference><Citation>Baxi, E.G., Thompson, T., Li, J., Kaye, J.A., Lim, R.G., Wu, J., Ramamoorthy, D., Lima, L., Vaibhav, V., Matlock, A. &#xa0;et al. (2022) Answer ALS, a large-scale resource for sporadic and familial ALS combining clinical and multi-omics data from induced pluripotent cell lines. Nat. Neurosci., 25, 226&#x2013;237.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8825283</ArticleId><ArticleId IdType="pubmed">35115730</ArticleId></ArticleIdList></Reference><Reference><Citation>Klim, J.R., Williams, L.A., Limone, F., Guerra San Juan, I., Davis-Dusenbery, B.N., Mordes, D.A., Burberry, A., Steinbaugh, M.J., Gamage, K.K., Kirchner, R. &#xa0;et al. (2019) ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nat. Neurosci., 22, 167&#x2013;179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7153761</ArticleId><ArticleId IdType="pubmed">30643292</ArticleId></ArticleIdList></Reference><Reference><Citation>Theunissen, F., Anderton, R.S., Mastaglia, F.L., Flynn, L.L., Winter, S.J., James, I., Bedlack, R., Hodgetts, S., Fletcher, S., Wilton, S.D. &#xa0;et al. (2021) Novel STMN2 variant linked to amyotrophic lateral sclerosis risk and clinical phenotype. Front. Aging Neurosci., 13, 658226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8033025</ArticleId><ArticleId IdType="pubmed">33841129</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanai, Y., Okada, Y., Tanaka, Y., Harada, A., Terada, S. and Hirokawa, N. (2000) KIF5C, a novel neuronal kinesin enriched in motor neurons. J. Neurosci., 20, 6374&#x2013;6384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772948</ArticleId><ArticleId IdType="pubmed">10964943</ArticleId></ArticleIdList></Reference><Reference><Citation>Padzik, A., Deshpande, P., Hollos, P., Franker, M., Rannikko, E.H., Cai, D., Prus, P., Magard, M., Westerlund, N., Verhey, K.J. &#xa0;et al. (2016) KIF5C S176 Phosphorylation regulates microtubule binding and transport efficiency in mammalian neurons. Front. Cell. Neurosci., 10, 57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4791394</ArticleId><ArticleId IdType="pubmed">27013971</ArticleId></ArticleIdList></Reference><Reference><Citation>Poirier, K., Lebrun, N., Broix, L., Tian, G., Saillour, Y., Boscheron, C., Parrini, E., Valence, S., Pierre, B.S., Oger, M. &#xa0;et al. (2013) Mutations in TUBG1, DYNC1H1, KIF5C and KIF2A cause malformations of cortical development and microcephaly. Nat. Genet., 45, 639&#x2013;647.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3826256</ArticleId><ArticleId IdType="pubmed">23603762</ArticleId></ArticleIdList></Reference><Reference><Citation>Michels, S., Foss, K., Park, K., Golden-Grant, K., Saneto, R., Lopez, J. and Mirzaa, G.M. (2017) Mutations of KIF5C cause a neurodevelopmental disorder of infantile-onset epilepsy, absent language, and distinctive malformations of cortical development. Am. J. Med. Genet. A, 173, 3127&#x2013;3131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5687290</ArticleId><ArticleId IdType="pubmed">29048727</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura, A.L., Mitne-Neto, M., Silva, H.C., Richieri-Costa, A., Middleton, S., Cascio, D., Kok, F., Oliveira, J.R., Gillingwater, T., Webb, J. &#xa0;et al. (2004) A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am. J. Hum. Genet., 75, 822&#x2013;831.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1182111</ArticleId><ArticleId IdType="pubmed">15372378</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuijpers, M., Yu, K.L., Teuling, E., Akhmanova, A., Jaarsma, D. and Hoogenraad, C.C. (2013) The ALS8 protein VAPB interacts with the ER-Golgi recycling protein YIF1A and regulates membrane delivery into dendrites. EMBO J., 32, 2056&#x2013;2072.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3715857</ArticleId><ArticleId IdType="pubmed">23736259</ArticleId></ArticleIdList></Reference><Reference><Citation>Tessadori, F., Giltay, J.C., Hurst, J.A., Massink, M.P., Duran, K., Vos, H.R., van &#xa0;Es, R.M., Deciphering Developmental Disorders, S, Scott, R.H., van &#xa0;Gassen, K.L.I. &#xa0;et al. (2017) Germline mutations affecting the histone H4 core cause a developmental syndrome by altering DNA damage response and cell cycle control. Nat. Genet., 49, 1642&#x2013;1646.</Citation><ArticleIdList><ArticleId IdType="pubmed">28920961</ArticleId></ArticleIdList></Reference><Reference><Citation>Byun, J.S., Oh, M., Lee, S., Gil, J.E., Mo, Y., Ku, B., Kim, W.K., Oh, K.J., Lee, E.W., Bae, K.H. &#xa0;et al. (2020) The transcription factor PITX1 drives astrocyte differentiation by regulating the SOX9 gene. J. Biol. Chem., 295, 13677&#x2013;13690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7521637</ArticleId><ArticleId IdType="pubmed">32759168</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun, W., Cornwell, A., Li, J., Peng, S., Osorio, M.J., Aalling, N., Wang, S., Benraiss, A., Lou, N., Goldman, S.A. &#xa0;et al. (2017) SOX9 Is an astrocyte-specific nuclear marker in the adult brain outside the neurogenic regions. J. Neurosci., 37, 4493&#x2013;4507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5413187</ArticleId><ArticleId IdType="pubmed">28336567</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Q., Ragnauth, C.D., Skepper, J.N., Worth, N.F., Warren, D.T., Roberts, R.G., Weissberg, P.L., Ellis, J.A. and Shanahan, C.M. (2005) Nesprin-2 is a multi-isomeric protein that binds lamin and emerin at the nuclear envelope and forms a subcellular network in skeletal muscle. J. Cell Sci., 118, 673&#x2013;687.</Citation><ArticleIdList><ArticleId IdType="pubmed">15671068</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, X., Xu, R., Zhu, B., Yang, X., Ding, X., Duan, S., Xu, T., Zhuang, Y. and Han, M. (2007) Syne-1 and Syne-2 play crucial roles in myonuclear anchorage and motor neuron innervation. Development, 134, 901&#x2013;908.</Citation><ArticleIdList><ArticleId IdType="pubmed">17267447</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman, S., Canny, M.D., Buschmann, T.A. and Latham, M.P. (2020) A survey of reported disease-related mutations in the MRE11-RAD50-NBS1 complex. Cell, 9, 1678.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7407228</ArticleId><ArticleId IdType="pubmed">32668560</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao, Y., Wang, J., Jaehnig, E.J., Shi, Z. and Zhang, B. (2019) WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs. Nucleic Acids Res., 47, W199&#x2013;W205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6602449</ArticleId><ArticleId IdType="pubmed">31114916</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzo, F., Nizzardo, M., Vashisht, S., Molteni, E., Melzi, V., Taiana, M., Salani, S., Santonicola, P., Di Schiavi, E., Bucchia, M. &#xa0;et al. (2019) Key role of SMN/SYNCRIP and RNA-Motif 7 in spinal muscular atrophy: RNA-Seq and motif analysis of human motor neurons. Brain, 142, 276&#x2013;294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6351774</ArticleId><ArticleId IdType="pubmed">30649277</ArticleId></ArticleIdList></Reference><Reference><Citation>Lelieveld, S.H., Reijnders, M.R., Pfundt, R., Yntema, H.G., Kamsteeg, E.J., de &#xa0;Vries, P., de &#xa0;Vries, B.B., Willemsen, M.H., Kleefstra, T., Lohner, K. &#xa0;et al. (2016) Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability. Nat. Neurosci., 19, 1194&#x2013;1196.</Citation><ArticleIdList><ArticleId IdType="pubmed">27479843</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillentine, M.A., Wang, T., Hoekzema, K., Rosenfeld, J., Liu, P., Guo, H., Kim, C.N., De Vries, B.B.A., Vissers, L., Nordenskjold, M. &#xa0;et al. (2021) Rare deleterious mutations of HNRNP genes result in shared neurodevelopmental disorders. Genome. Med., 13, 63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8056596</ArticleId><ArticleId IdType="pubmed">33874999</ArticleId></ArticleIdList></Reference><Reference><Citation>Busetto, V., Barbosa, I., Basquin, J., Marquenet, E., Hocq, R., Hennion, M., Paternina, J.A., Namane, A., Conti, E., Bensaude, O. &#xa0;et al. (2020) Structural and functional insights into CWC27/CWC22 heterodimer linking the exon junction complex to spliceosomes. Nucleic Acids Res., 48, 5670&#x2013;5683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7261170</ArticleId><ArticleId IdType="pubmed">32329775</ArticleId></ArticleIdList></Reference><Reference><Citation>Moretti, J., Chastagner, P., Gastaldello, S., Heuss, S.F., Dirac, A.M., Bernards, R., Masucci, M.G., Israel, A. and Brou, C. (2010) The translation initiation factor 3f (eIF3f) exhibits a deubiquitinase activity regulating Notch activation. PLoS Biol., 8, e1000545.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2990700</ArticleId><ArticleId IdType="pubmed">21124883</ArticleId></ArticleIdList></Reference><Reference><Citation>Elantak, L., Wagner, S., Herrmannova, A., Karaskova, M., Rutkai, E., Lukavsky, P.J. and Valasek, L. (2010) The indispensable N-terminal half of eIF3j/HCR1 cooperates with its structurally conserved binding partner eIF3b/PRT1-RRM and with eIF1A in stringent AUG selection. J. Mol. Biol., 396, 1097&#x2013;1116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2824034</ArticleId><ArticleId IdType="pubmed">20060839</ArticleId></ArticleIdList></Reference><Reference><Citation>Young, D.J. and Guydosh, N.R. (2019) Hcr1/eIF3j Is a 60S ribosomal subunit recycling accessory factor in vivo. Cell Rep., 28, 39, e34&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6661068</ArticleId><ArticleId IdType="pubmed">31269449</ArticleId></ArticleIdList></Reference><Reference><Citation>Nickel, W. and Rabouille, C. (2009) Mechanisms of regulated unconventional protein secretion. Nat. Rev. Mol. Cell Biol, 10, 148&#x2013;155.</Citation><ArticleIdList><ArticleId IdType="pubmed">19122676</ArticleId></ArticleIdList></Reference><Reference><Citation>Trychta, K.A., Back, S., Henderson, M.J. and Harvey, B.K. (2018) KDEL receptors are differentially regulated to maintain the ER proteome under calcium deficiency. Cell Rep., 25, 1829, e1826&#x2013;1840.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7336508</ArticleId><ArticleId IdType="pubmed">30428351</ArticleId></ArticleIdList></Reference><Reference><Citation>Annaert, W.G., Becker, B., Kistner, U., Reth, M. and Jahn, R. (1997) Export of cellubrevin from the endoplasmic reticulum is controlled by BAP31. J. Cell Biol., 139, 1397&#x2013;1410.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2132629</ArticleId><ArticleId IdType="pubmed">9396746</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakana, Y., Takai, S., Nakajima, K., Tani, K., Yamamoto, A., Watson, P., Stephens, D.J., Hauri, H.P. and Tagaya, M. (2008) Bap31 is an itinerant protein that moves between the peripheral endoplasmic reticulum (ER) and a juxtanuclear compartment related to ER-associated Degradation. Mol. Biol. Cell, 19, 1825&#x2013;1836.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2366873</ArticleId><ArticleId IdType="pubmed">18287538</ArticleId></ArticleIdList></Reference><Reference><Citation>Namba, T. (2019) BAP31 regulates mitochondrial function via interaction with Tom40 within ER-mitochondria contact sites. Sci. Adv., 5, eaaw1386.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6561740</ArticleId><ArticleId IdType="pubmed">31206022</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin, H., Komita, M. and Aoe, T. (2017) The role of BiP retrieval by the KDEL receptor in the early secretory pathway and its effect on protein quality control and neurodegeneration. Front. Mol. Neurosci., 10, 222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5511815</ArticleId><ArticleId IdType="pubmed">28769758</ArticleId></ArticleIdList></Reference><Reference><Citation>Whalen, S., Shaw, M., Mignot, C., Heron, D., Bastaraud, S.C., Walti, C.C., Liebelt, J., Elmslie, F., Yap, P., Hurst, J. &#xa0;et al. (2021) Further delineation of BCAP31-linked intellectual disability: description of 17 new families with LoF and missense variants. Eur. J. Hum. Genet., 29, 1405&#x2013;1417 &#xa0;in press.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8440520</ArticleId><ArticleId IdType="pubmed">33603160</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominissini, D., Nachtergaele, S., Moshitch-Moshkovitz, S., Peer, E., Kol, N., Ben-Haim, M.S., Dai, Q., Di Segni, A., Salmon-Divon, M., Clark, W.C. &#xa0;et al. (2016) The dynamic N(1)-methyladenosine methylome in eukaryotic messenger RNA. Nature, 530, 441&#x2013;446.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4842015</ArticleId><ArticleId IdType="pubmed">26863196</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, C. and Jia, G. (2018) Reversible RNA modification N(1)-methyladenosine (m(1)A) in mRNA and tRNA. Genomics Proteomics Bioinformatics, 16, 155&#x2013;161.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6076376</ArticleId><ArticleId IdType="pubmed">29908293</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, X., Xiong, X., Zhang, M., Wang, K., Chen, Y., Zhou, J., Mao, Y., Lv, J., Yi, D., Chen, X.W. &#xa0;et al. (2017) Base-resolution mapping reveals distinct m(1)A methylome in nuclear- and mitochondrial-encoded transcripts. Mol. Cell, 68, 993, e1009&#x2013;1005.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5722686</ArticleId><ArticleId IdType="pubmed">29107537</ArticleId></ArticleIdList></Reference><Reference><Citation>Sattler, R. and Rothstein, J.D. (2006) Regulation and dysregulation of glutamate transporters. Handb. Exp. Pharmacol, 175, 277&#x2013;303.</Citation><ArticleIdList><ArticleId IdType="pubmed">16722241</ArticleId></ArticleIdList></Reference><Reference><Citation>Sears, T.K. and Angelastro, J.M. (2017) The transcription factor ATF5: role in cellular differentiation, stress responses, and cancer. Oncotarget, 8, 84595&#x2013;84609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5663623</ArticleId><ArticleId IdType="pubmed">29137451</ArticleId></ArticleIdList></Reference><Reference><Citation>Langfelder, P. and Horvath, S. (2008) WGCNA: an R package for weighted correlation network analysis. BMC Bioinform., 9, 559.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2631488</ArticleId><ArticleId IdType="pubmed">19114008</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, B. and Horvath, S. (2005) A general framework for weighted gene co-expression network analysis. Stat. Appl. Genet. Mol. Biol., 4, Article17.</Citation><ArticleIdList><ArticleId IdType="pubmed">16646834</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaiteri, C., Ding, Y., French, B., Tseng, G.C. and Sibille, E. (2014) Beyond modules and hubs: the potential of gene coexpression networks for investigating molecular mechanisms of complex brain disorders. Genes Brain Behav., 13, 13&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3896950</ArticleId><ArticleId IdType="pubmed">24320616</ArticleId></ArticleIdList></Reference><Reference><Citation>Langfelder, P., Luo, R., Oldham, M.C. and Horvath, S. (2011) Is my network module preserved and reproducible? &#xa0;PLoS Comput. Biol., 7, e1001057.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3024255</ArticleId><ArticleId IdType="pubmed">21283776</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernardini, C., Censi, F., Lattanzi, W., Barba, M., Calcagnini, G., Giuliani, A., Tasca, G., Sabatelli, M., Ricci, E. and Michetti, F. (2013) Mitochondrial network genes in the skeletal muscle of amyotrophic lateral sclerosis patients. PLoS One, 8, e57739.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3585165</ArticleId><ArticleId IdType="pubmed">23469062</ArticleId></ArticleIdList></Reference><Reference><Citation>Taghibiglou, C., Lu, J., Mackenzie, I.R., Wang, Y.T. and Cashman, N.R. (2011) Sterol regulatory element binding protein-1 (SREBP1) activation in motor neurons in excitotoxicity and amyotrophic lateral sclerosis (ALS): Indip, a potential therapeutic peptide. Biochem. Biophys. Res. Commun., 413, 159&#x2013;163.</Citation><ArticleIdList><ArticleId IdType="pubmed">21871872</ArticleId></ArticleIdList></Reference><Reference><Citation>Dangoumau, A., Marouillat, S., Coelho, R., Wurmser, F., Brulard, C., Haouari, S., Laumonnier, F., Corcia, P., Andres, C.R., Blasco, H. &#xa0;et al. (2021) Dysregulations of expression of genes of the Ubiquitin/SUMO pathways in an in vitro model of amyotrophic lateral sclerosis combining oxidative stress and SOD1 gene mutation. Int. J. Mol. Sci., 22, 1796.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7918082</ArticleId><ArticleId IdType="pubmed">33670299</ArticleId></ArticleIdList></Reference><Reference><Citation>Morahan, J.M., Yu, B., Trent, R.J. and Pamphlett, R. (2007) Genetic susceptibility to environmental toxicants in ALS. Am. J. Med. Genet. B Neuropsychiatr. Genet., 144B, 885&#x2013;890.</Citation><ArticleIdList><ArticleId IdType="pubmed">17503480</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, K.Y., Kim, Y.R., Choi, K.W., Lee, M., Lee, S., Im, W., Shin, J.Y., Kim, J.Y., Hong, Y.H., Kim, M. &#xa0;et al. (2020) Downregulated miR-18b-5p triggers apoptosis by inhibition of calcium signaling and neuronal cell differentiation in transgenic SOD1 (G93A) mice and SOD1 (G17S and G86S) ALS patients. Transl. Neurodegener., 9, 23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7328278</ArticleId><ArticleId IdType="pubmed">32605607</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu, Z., Snitkin, E.S. and DeLisi, C. (2008) VisANT: an integrative framework for networks in systems biology. Brief. Bioinform., 9, 317&#x2013;325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2743399</ArticleId><ArticleId IdType="pubmed">18463131</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronica, E., Baas, F., Iyer, A., ten &#xa0;Asbroek, A.L., Morello, G. and Cavallaro, S. (2015) Molecular classification of amyotrophic lateral sclerosis by unsupervised clustering of gene expression in motor cortex. Neurobiol. Dis., 74, 359&#x2013;376.</Citation><ArticleIdList><ArticleId IdType="pubmed">25500340</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, J.C., Ramaswami, G. and Geschwind, D.H. (2021) Gene co-expression network analysis in human spinal cord highlights mechanisms underlying amyotrophic lateral sclerosis susceptibility. Sci. Rep., 11, 5748.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7970949</ArticleId><ArticleId IdType="pubmed">33707641</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostafavi, S., Gaiteri, C., Sullivan, S.E., White, C.C., Tasaki, S., Xu, J., Taga, M., Klein, H.U., Patrick, E., Komashko, V. &#xa0;et al. (2018) A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer's disease. Nat. Neurosci., 21, 811&#x2013;819.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6599633</ArticleId><ArticleId IdType="pubmed">29802388</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun, Y., Lin, J. and Zhang, L. (2019) The application of weighted gene co-expression network analysis in identifying key modules and hub genes associated with disease status in Alzheimer's disease. Ann. Transl. Med, 7, 800.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6989876</ArticleId><ArticleId IdType="pubmed">32042816</ArticleId></ArticleIdList></Reference><Reference><Citation>Park, D.S., Morris, E.J., Padmanabhan, J., Shelanski, M.L., Geller, H.M. and Greene, L.A. (1998) Cyclin-dependent kinases participate in death of neurons evoked by DNA-damaging agents. J. Cell Biol., 143, 457&#x2013;467.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2132832</ArticleId><ArticleId IdType="pubmed">9786955</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Y., Song, X. and Herrup, K. (2020) Context-dependent functions of E2F1: cell cycle, cell death, and DNA damage repair in cortical neurons. Mol. Neurobiol., 57, 2377&#x2013;2390.</Citation><ArticleIdList><ArticleId IdType="pubmed">32062842</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranganathan, S. and Bowser, R. (2003) Alterations in G(1) to S phase cell-cycle regulators during amyotrophic lateral sclerosis. Am. J. Pathol., 162, 823&#x2013;835.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1868100</ArticleId><ArticleId IdType="pubmed">12598317</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph, C., Mangani, A.S., Gupta, V., Chitranshi, N., Shen, T., Dheer, Y., Kb, D., Mirzaei, M., You, Y., Graham, S.L. &#xa0;et al. (2020) Cell cycle deficits in neurodegenerative disorders: uncovering molecular mechanisms to drive innovative therapeutic development. Aging Dis., 11, 946&#x2013;966.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7390532</ArticleId><ArticleId IdType="pubmed">32765956</ArticleId></ArticleIdList></Reference><Reference><Citation>Denechaud, P.D., Fajas, L. and Giralt, A. (2017) E2F1, a novel regulator of metabolism. Front Endocrinol. (Lausanne), 8, 311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5686046</ArticleId><ArticleId IdType="pubmed">29176962</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu, H., Lee, J., Zaman, K., Kubilis, J., Ferrante, R.J., Ross, B.D., Neve, R. and Ratan, R.R. (2003) Sp1 and Sp3 are oxidative stress-inducible, antideath transcription factors in cortical neurons. J. Neurosci., 23, 3597&#x2013;3606.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6742168</ArticleId><ArticleId IdType="pubmed">12736330</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Morales, V., Rodriguez-Bey, G., Gomez-Perez, L., Dominguez-Vias, G., Gonzalez-Forero, D., Portillo, F., Campos-Caro, A., Gento-Caro, A., Issaoui, N., Soler, R.M. &#xa0;et al. (2019) Sp1-regulated expression of p11 contributes to motor neuron degeneration by membrane insertion of TASK1. Nat. Commun., 10, 3784.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6706379</ArticleId><ArticleId IdType="pubmed">31439839</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotheneder, H., Geymayer, S. and Haidweger, E. (1999) Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter. J. Mol. Biol., 293, 1005&#x2013;1015.</Citation><ArticleIdList><ArticleId IdType="pubmed">10547281</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, X., Song, S. and Peng, W. (2021) Cell cycle deregulation in neurodegenerative diseases. Int. J. Neurosci., in press., 1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">33945388</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas, A., Kenna, K.P., Renton, A.E., Ticozzi, N., Faghri, F., Chia, R., Dominov, J.A., Kenna, B.J., Nalls, M.A., Keagle, P. &#xa0;et al. (2018) genome-wide analyses identify KIF5A as a novel ALS gene. Neuron, 97, 1268, e1266&#x2013;e1283.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5867896</ArticleId><ArticleId IdType="pubmed">29566793</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello, G., Guarnaccia, M., Spampinato, A.G., Salomone, S., D'Agata, V., Conforti, F.L., Aronica, E. and Cavallaro, S. (2019) Integrative multi-omic analysis identifies new drivers and pathways in molecularly distinct subtypes of ALS. Sci. Rep., 9, 9968.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6620285</ArticleId><ArticleId IdType="pubmed">31292500</ArticleId></ArticleIdList></Reference><Reference><Citation>Veyrat-Durebex, C., Bris, C., Codron, P., Bocca, C., Chupin, S., Corcia, P., Vourc'h, P., Hergesheimer, R., Cassereau, J., Funalot, B. &#xa0;et al. (2019) Metabo-lipidomics of fibroblasts and mitochondrial-endoplasmic reticulum extracts from ALS patients shows alterations in purine, pyrimidine, energetic, and phospholipid metabolisms. Mol. Neurobiol., 56, 5780&#x2013;5791.</Citation><ArticleIdList><ArticleId IdType="pubmed">30680691</ArticleId></ArticleIdList></Reference><Reference><Citation>Fishel, M.L., Vasko, M.R. and Kelley, M.R. (2007) DNA repair in neurons: so if they don't divide what's to repair? &#xa0;Mutat. Res., 614, 24&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">16879837</ArticleId></ArticleIdList></Reference><Reference><Citation>Penndorf, D., Witte, O.W. and Kretz, A. (2018) DNA plasticity and damage in amyotrophic lateral sclerosis. Neural Regen. Res., 13, 173&#x2013;180.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5879878</ArticleId><ArticleId IdType="pubmed">29557356</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz, E.I., Smilenov, L.B., Price, M.A., Osredkar, T., Baker, R.A., Ghosh, S., Shi, F.D., Vollmer, T.L., Lencinas, A., Stearns, D.M. &#xa0;et al. (2007) Cell cycle activation in postmitotic neurons is essential for DNA repair. Cell Cycle, 6, 318&#x2013;329.</Citation><ArticleIdList><ArticleId IdType="pubmed">17297309</ArticleId></ArticleIdList></Reference><Reference><Citation>Coppede, F. (2011) An overview of DNA repair in amyotrophic lateral sclerosis. Sci. World J., 11, 1679&#x2013;1691.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3201689</ArticleId><ArticleId IdType="pubmed">22125427</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolger, A.M., Lohse, M. and Usadel, B. (2014) Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics, 30, 2114&#x2013;2120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4103590</ArticleId><ArticleId IdType="pubmed">24695404</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin, A., Davis, C.A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M. and Gingeras, T.R. (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics, 29, 15&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R. and Genome Project Data Processing, S (2009) The sequence alignment/map format and SAMtools. Bioinformatics, 25, 2078&#x2013;2079.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2723002</ArticleId><ArticleId IdType="pubmed">19505943</ArticleId></ArticleIdList></Reference><Reference><Citation>Anders, S., Pyl, P.T. and Huber, W. (2015) HTSeq--a Python framework to work with high-throughput sequencing data. Bioinformatics, 31, 166&#x2013;169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4287950</ArticleId><ArticleId IdType="pubmed">25260700</ArticleId></ArticleIdList></Reference><Reference><Citation>Love, M.I., Huber, W. and Anders, S. (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol., 15, 550.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia, J., Psychogios, N., Young, N. and Wishart, D.S. (2009) MetaboAnalyst: a web server for metabolomic data analysis and interpretation. Nucleic Acids Res., 37, W652&#x2013;W660.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2703878</ArticleId><ArticleId IdType="pubmed">19429898</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, T., Hu, E., Xu, S., Chen, M., Guo, P., Dai, Z., Feng, T., Zhou, L., Tang, W., Zhan, L. &#xa0;et al. (2021) clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation (N Y), 2, 100141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8454663</ArticleId><ArticleId IdType="pubmed">34557778</ArticleId></ArticleIdList></Reference><Reference><Citation>Raudvere, U., Kolberg, L., Kuzmin, I., Arak, T., Adler, P., Peterson, H. and Vilo, J. (2019) g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update). Nucleic Acids Res., 47, W191&#x2013;W198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6602461</ArticleId><ArticleId IdType="pubmed">31066453</ArticleId></ArticleIdList></Reference><Reference><Citation>Granatiero, V., Sayles, N.M., Savino, A.M., Konrad, C., Kharas, M.G., Kawamata, H. and Manfredi, G. (2021) Modulation of the IGF1R-MTOR pathway attenuates motor neuron toxicity of human ALS SOD1(G93A) astrocytes. Autophagy, 17, 4029&#x2013;4042, in press, 1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8726657</ArticleId><ArticleId IdType="pubmed">33749521</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie, M.E., Phipson, B., Wu, D., Hu, Y., Law, C.W., Shi, W. and Smyth, G.K. (2015) limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res., 43, e47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4402510</ArticleId><ArticleId IdType="pubmed">25605792</ArticleId></ArticleIdList></Reference><Reference><Citation>Galili, T. (2015) dendextend: an R package for visualizing, adjusting and comparing trees of hierarchical clustering. Bioinformatics, 31, 3718&#x2013;3720.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4817050</ArticleId><ArticleId IdType="pubmed">26209431</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker, F.B. and Hubert, L.J. (1975) Measuring the power of hierarchical cluster analysis. J. Am. Calif. Assoc., 70, 31&#x2013;38.</Citation></Reference><Reference><Citation>Kuhn, M. (2012) The caret Package. J. Stat. Softw., 28, 1&#x2013;26.</Citation></Reference><Reference><Citation>Sing, T., Sander, O., Beerenwinkel, N. and Lengauer, T. (2005) ROCR: visualizing classifier performance in R. Bioinformatics, 21, 3940&#x2013;3941.</Citation><ArticleIdList><ArticleId IdType="pubmed">16096348</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>